Lennar news

The WiseView Research desk's stories that name Lennar, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The LEN page →

  • Market closeS&P 500 Falls 1.2%, Nasdaq Sinks 2.6% as Tech Earnings Disappoint

    The S&P 500 dropped 1.22% and the Nasdaq slid 2.6% Thursday as tech names sold off, while the Dow eked out a small gain.

    WiseView Research desk · October 22, 2026 at 8:59 PM ET
  • CongressRo Khanna sold $1,001 - $15,000 of LENHouse · D-California · traded Sep 11, 2026 · disclosed Oct 9, 2026
  • CongressRo Khanna sold $1,001 - $15,000 of LENHouse · D-California · traded Sep 25, 2026 · disclosed Oct 9, 2026
  • HeadlineThe 30-Year Mortgage Is Closing In on 7.5%24/7 Wall Street · October 7, 2026 at 12:33 PM ET
  • CongressRo Khanna bought $1,001 - $15,000 of LENHouse · D-California · traded Aug 10, 2026 · disclosed Sep 7, 2026
  • CongressRo Khanna sold $1,001 - $15,000 of LENHouse · D-California · traded Jul 7, 2026 · disclosed Aug 12, 2026
  • CongressRo Khanna bought $1,001 - $15,000 of LENHouse · D-California · traded May 1, 2026 · disclosed Jun 11, 2026
  • CongressRo Khanna bought $1,001 - $15,000 of LENHouse · D-California · traded Apr 13, 2026 · disclosed May 13, 2026
  • CongressGilbert Cisneros sold $1,001 - $15,000 of LENHouse · D-California · traded Jan 9, 2026 · disclosed Feb 16, 2026
  • CongressGilbert Cisneros sold $1,001 - $15,000 of LENHouse · D-California · traded Dec 19, 2025 · disclosed Jan 13, 2026

Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.

Follow LEN in the terminal.

Membership details

14-day free trial · no card needed · nothing to cancel.

Then $83/mo billed annually — $997 once a year.

WiseView provides market data and research tools for educational purposes. Nothing here is investment advice. Past performance does not predict future results.